A doctor’s signature on a diagnostic report traditionally serves as a guarantee that a qualified professional has carefully evaluated the findings and takes responsibility for the interpretation. Recent clarifications from regulatory authorities, however, have brought renewed attention to allegations of ghost pathologists whose credentials are used to sign off on medical tests they have never actually examined.
The National Medical Commission issued a clarification stating that existing regulations do not prohibit registered medical practitioners from remotely reviewing and authenticating electronic laboratory, pathology, and radiology reports through legally recognized digital signatures. The commission emphasized that such remote sign-offs are valid only after the practitioner has thoroughly reviewed all necessary clinical information and independently determined that the report is accurate and ready for authentication. If the available data is insufficient, the doctor is required to withhold approval until a complete review is finished.
Medical professionals advocating against credential misuse note that legitimate remote evaluations differ significantly from laboratories issuing reports under a doctor's name without their direct involvement. Critics argue that some diagnostic centers print physician names or digital signatures on reports automatically, with a single pathologist's credentials occasionally being stretched across multiple facilities in different cities while leaving patient results unchecked. Industry veterans point out that this unauthorized practice undermines diagnostic accuracy, potentially leading to delayed treatments or missed medical conditions.
Concerns have also been raised regarding laboratories empanelled under the Central Government Health Scheme, which provides medical coverage to central government employees and retirees. Despite strict requirements mandating full accreditation from the National Accreditation Board for Testing and Calibration Laboratories for participating facilities, complaints allege that even accredited centers have engaged in releasing reports under pathologists who failed to perform proper reviews. Because these empanelled labs receive public funding, any lack of oversight risks exposing both patients and government resources to systemic failures.
The scale of the diagnostic industry further complicates enforcement, with estimates indicating a vast number of laboratories operating across the country compared to the limited pool of accredited facilities and available specialists. While parent organizations like the Quality Council of India acknowledge that reports authorized by unauthorized personnel violate accreditation criteria, watchdogs continue to press for tighter identity-bound digital safeguards. Proposed measures include preventing the use of reusable signature images and ensuring rigorous audit trails to confirm that designated medical professionals actively approve every diagnostic report.